Three-dimensional angioarchitecture in transplantable rat fibrosarcomas.

J Comp Pathol

Department of Toxicology and Safety Assessment, Kawanishi Pharma Research Institute, Nippon Boehringer Ingelheim Co Ltd, 3-10-1, Yato, Kawanishi Hyogo 666-0193, Japan.

Published: January 2002

Three-dimensional angioarchitecture in a transplantable fibrosarcoma (SS) in F344 rats was investigated by scanning electron microscopy (SEM) of vascular corrosion casts. Tumours were produced in syngeneic rats by implantation of a tumour fragment from another SS tumour. Viable SS tumours, observed up to post-implantation (PI) week 5, showed a high degree of vascularization, consisting of arterioles and veins, and intertwining capillaries branching from such vessels. The capillaries showed numerous finger-like outgrowths, indicating active sprouting of endothelial cells and contributing to tumour growth. In contrast, SS tumours in rats given a single dose (4 mg/kg/bodyweight) of cisplatin at PI week 1 were reduced in volume, lacking in capillary outgrowths, and of low vascular density. Necrotic areas in SS tumours were surrounded by capillaries with sharp tips and wrinkled surfaces. Thus, the findings indicated differences in three-dimensional angioarchitecture between vigorously developing tumours and (1) tumours degenerating as the result of treatment with an anti-cancer drug, or (2) necrotic tumour tissues. SEM of vascular corrosion casts may prove useful for the evaluation of neovascularization in mesenchymal tumours.

Download full-text PDF

Source
http://dx.doi.org/10.1053/jcpa.2001.0505DOI Listing

Publication Analysis

Top Keywords

three-dimensional angioarchitecture
12
angioarchitecture transplantable
8
sem vascular
8
vascular corrosion
8
corrosion casts
8
tumours
7
transplantable rat
4
rat fibrosarcomas
4
fibrosarcomas three-dimensional
4
transplantable fibrosarcoma
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!